Hyaluronidase treatment of acute lymphedema in a mouse tail model

Lymphology

Volumn 46, Issue 4, 2013, Pages 160-172

  Jeong, H J ^a   Roh, K H ^a   Kim, G C ^a   Kim, Y O ^a   Lee, J H ^a   Lee, M J ^a   Sim, Young Joo ^a  

^a Kosin University College of Medicine   (South Korea)

Author keywords

Fibrosis; Hyaluronidase; Inflammation; Lymphangiogenesis; Lymphedema; Mouse tail

Indexed keywords

BMHYLUNIDASE INJ; HERMES ANTIGEN; HYALURONIDASE; PODOPLANIN; TILETAMINE PLUS ZOLAZEPAM; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ACUTE LYMPHEDEMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; FEMALE; FIBROSIS; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTERSTITIAL FLUID; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC DRAINAGE; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD44; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; HYALURONOGLUCOSAMINIDASE; INJECTIONS, INTRALESIONAL; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; LYMPHEDEMA; MEMBRANE GLYCOPROTEINS; MICE; NEUTROPHILS; TAIL; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84896787889     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nakamura, K, R Kavita, YT Wong, et al: Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS ONE 4 (2009), e8380.
2. Rockson SG: Diagnosis and management of lymphatic vascular disease. J. Am. Coll. Cardiol. 52 (2008), 799-806.
3. Liu, NF, LR Zhang: Changes of tissue fluid hyaluronan (hyaluronic acid) in peripheral lymphedema. Lymphology 31 (1998), 173-179. (Pubitemid 29056710)
4. Liu, N, L Shao, X Xu, et al: Hyaluronan metabolism in rat tail skin following blockage of the lymphatic circulation. Lymphology 35 (2002), 15-22. (Pubitemid 34267203)
5. Liu, NF: Trafficking of hyaluronan in the interstitium and its possible implications. Lymphology 37 (2004), 6-14.
6. Földi, E, A Sauerwald, B Hennig: Effect of complex decongestive physiotherapy on gene expression for the inflammatory response in peripheral lymphedema. Lymphology 33 (2000), 19-23. (Pubitemid 30198825)
7. Tabibiazar, R, L Cheung, J Han, et al: Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med. 3 (2006), e254.
8. Laugier, JP, S Shuster, M Rosdy, et al: Topical hyaluronidase decreases hyaluronic acid and CD44 in human skin and in reconstituted human epidermis: Evidence that hyaluronidase can permeate the stratum corneum. Br. J. Dermatol. 142 (2000), 226-233.
9. Jeong, HJ, KH Hwang, YJ Sim, et al: The study of animal model of lymphedema using the mouse tail. Kosin Med. J. 27 (2012), 141-149.
10. Taylor, R, UW Jayasinghe, L Koelmeyer, et al: Reliability and validity of arm volume measurements for assessment of lymphedema. Phys. Ther. 86 (2006), 205-214. (Pubitemid 43190716)
11. Liu, N: Metabolism of macromolecules in tissue. Lymphat. Res. Biol. 1 (2003), 67-70.
12. McKee, CM, MB Penno, M Cowman, et al: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98 (1996), 2403-2413.
13. Noble, PW: Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 21 (2002), 25-29.
14. Lee, A, SE Grummer, D Kriegel, et al: Hyaluronidase. Dermatol. Surg. 36 (2010), 1071-1077.
15. Fraser, JR, WG Kimpton, TC Laurent, et al: Uptake and degradation of hyaluronan in lymphatic tissue. Biochem. J. 256 (1988), 153-158.
16. Clavin, NW, T Avraham, J Fernandez, et al: TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H2113-2127.
17. Jin da, P, A An, J Liu, et al: Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: Immunohistochemical and molecular characterization. Lymphat. Res. Biol. 7 (2009), 47-57.
18. Yoon, YS, T Murayama, E Gravereaux, et al: VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J. Clin. Invest. 111 (2003), 717-725. (Pubitemid 36278590)
19. Szuba, A, M Skobe, MJ Karkkainen, et al: Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16 (2002), 1985-1987.
20. Huggenberger, R, S Ullmann, ST Proulx, et al: Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J. Exp. Med. 207 (2010), 2255-2269.
21. Huggenberger, R, SS Siddiqui, D Brander, et al: An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117 (2011), 4667-4678.
22. Teder, P, RW Vandivier, D Jiang, et al: Resolution of lung inflammation by CD44. Science 296 (2002), 155-158. (Pubitemid 34280077)
23. Hwang, JH, IG Kim, JY Lee, et al: Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials 32 (2011), 4415-4423.
24. Conrad, C, H Niess, R Huss, et al: Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation 119 (2009), 281-289.
25. Mandriota, SJ, L Jussila, M Jeltsch, et al: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20 (2001), 672-682. (Pubitemid 32167632)
26. Yiannakopoulou, E: Modulation of Lymphangiogenesis: A new target for aspirin and other nonsteroidal anti-inflammatory agents? A systematic review. J. Clin. Pharmacol. 11 (2011), 1749-1754.
27. Campo, GM, A Avenoso, A D'Ascola, et al: Inhibition of hyaluronan synthesis reduced inflammatory response in mouse synovial fibroblasts subjected to collage-induced arthritis. Arch. Biochem. Biophys. 518 (2012), 42-52.
28. Caskey, RC, M Allukian, RC Lind, et al: Lentiviral-mediated over-expression of hyaluronan synthase-1 (HAS-1) decreases the cellular inflammatory response and results in regenerative wound repair. Cell Tissue Res. 351 (2013), 117-125.